The Association of the British Pharmaceutical Industry
Medicines are transforming our lives like never before.
We want the UK to be the best place in the world to research, develop and use the medicines and vaccines of the future.
Global pharmaceutical industry leaders meet with UK Prime Minister to discuss leadership in global health and innovation
London, 3 December, 2021 – Yesterday, global leaders from the pharmaceutical industry met with the Prime Minister, senior UK Cabinet Ministers and the NHS Chief Executive, to discuss global health and innovation.
Biopharmaceutical industry collaborates on the implementation of the G7 100 Days Mission to improve readiness for future pandemics
The biopharmaceutical industry welcomes the publication of the 100 Days Mission - First Implementation Report released on 2 December, which maps out key actions needed from all stakeholders to build global pandemic preparedness.
Science is thriving in UK regions: Government must back them
ABPI, CBI, and Birmingham Health Partners (BHP) report shines a light on life sciences in one region – the West Midlands.
Pharmaceutical industry sets out its vision for the future UK medicines regulation
Britain should work with its ‘science allies’ abroad and develop medicines regulation for emerging technologies at home to build a globally attractive life sciences sector fit for the 2020s, or it risks being left behind.
Latest blogs and events
Antibiotic resistance: A global, silent pandemic that is solvable
ABPI President Ben Osborn explains the problem of antibiotic resistance and what we can do about it.
Invest and innovate to keep UK life sciences globally competitive
Richard Torbett outlines the case for investing in our sector ahead of the autumn's Comprehensive Spending Review.
ABPI & AAC ATMP Roadmap launch webinar | 9 Dec 2021
We are delighted to invite you to the launch of the brand new Accelerated Access Collaborative/ABPI Advanced Therapeutic Medicinal Products (ATMP) Roadmap.
Online Workshop on SMC: How to prepare and submit to SMC | 13-14 Dec 2021
Making high quality, evidence-based submissions to SMC can mean the difference between successful or very limited access to NHS Scotland for medicines.
Key content hubs
The COP26 summit will bring parties together to accelerate action towards the goals of the Paris Agreement and the UN Framework Convention on Climate Change.
Coronavirus (COVID-19) was officially declared a pandemic by the World Health Organization on 12 March 2020. As a critical part of the health care community in the UK, the pharmaceutical industry wants to play the biggest possible role in the response to this outbreak.
The ABPI Code of Practice sets out the requirements the industry must comply with and supports companies’ commitment to self-regulation and to operate in a professional, ethical and transparent manner.
Rare diseases have a devastating impact on people’s lives: pharmaceutical companies here in the UK and around the world are working to change that – developing new medicines to give families hope for the future.
Thanks to @maggie_erewash for responding to all the points made at today's debate on #AMR. We want to work with Government to help raise awareness of this problem & solve it together 🔬💊https://t.co/GrLB7hWnj1 #togetherforantibiotics— ABPI (@ABPI_UK) December 7, 2021